Skip to content
Subscriber Only

Ex-Hospira CEO Trades Shares for $91 Million Cash in Pfizer Deal

  • Pfizer completed purchase of injectable drugmaker Sept. 3
  • Executive's options vested in $90-a-share acquisition

Michael Ball, former chief executive officer Hospira Inc., the biggest injectable-drug maker, made $91.1 million on the sale of his company’s shares to Pfizer Inc.

Ball, who had run Lake Forest, Illinois-based Hospira since 2011, had 1.41 million shares and options when Pfizer completed its purchase of the company at $90 a share today, according to a regulatory filing. He spent $36 million to exercise his options, then sold shares valued at $127.1 million, according to data compiled from the filing.